Altre lingue Ind-Swift Laboratories Limited

Azioni

INDSWFTLAB

INE915B01019

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:43:54 14/06/2024			Variaz. 5gg	Var. 1 gen.
118,2 ^INR	-0,77%		+3,17%	+14,18%

18/05	Ind-Swift Laboratories Ltd. annuncia l'incorporazione ai sensi del Regolamento 30 per quanto riguarda l'incorporazione di ISLL Middle East L.L.C-FZ	CI
13/05	Ind-Swift Laboratories Limited riporta i risultati degli utili per l'intero anno terminato il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Ind-Swift Laboratories Ltd. Announces Incorporation Under Regulation 30 Regarding Incorporation of ISLL Middle East L.L.C-FZ	18/05
Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	13/05
Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	13/05
Ind-Swift Laboratories to Incorporate Wholly-Owned Arm in Dubai	19/04
Ind-Swift Laboratories Limited Announces Incorporation of Wholly Owned Subsidiary	19/04
Ind-Swift Laboratories Limited Announces Cessation of Sunil Deshmukh as Chief Executive Officer	18/03
Ind-Swift Laboratories Limited Announces Cessation of Lovekesh Mahajan as Chief Accounts Officer	18/03
Ind-Swift Laboratories Limited Redeems in Full, the 4245 Rated, Listed, Secured, 10% Coupon, Redeemable, Non-Convertible Debenture	18/03
Synthimed Labs Private Limited agreed to acquire API and CRAMS business of Ind-Swift Laboratories Limited and Essix Biosciences Limited.	18/03
Ind-Swift Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
CARE Keeps BB Rating on Ind-Swift Laboratories' Long-term Financing; Rating Under Watch Developing	20/12
Ind-Swift Laboratories Limited Collaborates with The Council of Scientific and Industrial Research	29/11
Ind-Swift Laboratories Limited Reports Earnings Results for the Half Year Ended September 30, 2023	07/11
Ind-Swift Laboratories Limited agreed to acquire Ind-Swift Limited.	25/09/23
IndiaRF to acquire API and CRAMS business of Ind-Swift Laboratories Limited for INR 1,650 Crores	07/09/23
Ind-Swift Gets Board Nod to Secure INR6 Billion Loan from Ind-Swift Laboratories	06/09/23
India's Ind-Swift Labs to sell pharma ingredients ops for $198.5 million	06/09/23
Synthimed Labs Private Limited agreed to acquire API and CRAMS business of Ind-Swift Laboratories Limited for INR 16.5 billion.	06/09/23
Ind-Swift Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	09/08/23
Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29/05/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ind-Swift Laboratories Limited

Azioni

INDSWFTLAB

INE915B01019

Altre lingue

Filtri